WallStreetZenWallStreetZen

Sectors & IndustriesHealthcareDiagnostics & Research
Best Diagnostics & Research Stocks to Buy Now (2022)
Top diagnostics & research stocks in 2022 ranked by overall Zen Score. See the best diagnostics & research stocks to buy now, according to analyst forecasts for the diagnostics & research industry.

Industry: Diagnostics & Research
Ticker
Company
Exchange
Industry
Zen Score
Market Cap
Price
1d %
EBITDA
P/E
D/E
QDEL
QUIDEL CORP
NASDAQ
Diagnostics & Research
$4.20B$100.40-0.84%$1.36B4.20x0.28
CODX
CO-DIAGNOSTICS INC
NASDAQ
Diagnostics & Research
$154.30M$4.54-9.02%$49.38M3.36x0.16
SYNH
SYNEOS HEALTH INC
NASDAQ
Diagnostics & Research
$7.24B$70.56-1.27%$633.22M30.15x1.52
MEDP
MEDPACE HOLDINGS INC
NASDAQ
Diagnostics & Research
$4.49B$133.32-0.30%$256.76M23.81x1.22
LHDX
LUCIRA HEALTH INC
NASDAQ
Diagnostics & Research
$81.73M$2.05-2.84%-$31.91M-2.16x0.49
DRIO
DARIOHEALTH CORP
NASDAQ
Diagnostics & Research
$140.27M$6.38-2.30%-$73.77M-1.60x0.12
FLGT
FULGENT GENETICS INC
NASDAQ
Diagnostics & Research
$1.63B$53.87-4.57%$632.68M3.49x0.12
TWST
TWIST BIOSCIENCE CORP
NASDAQ
Diagnostics & Research
$1.97B$34.94-6.63%-$183.96M-9.47x0.18
DMTK
DERMTECH INC
NASDAQ
Diagnostics & Research
$180.24M$6.02-3.37%-$90.47M-1.91x0.18
DGX
QUEST DIAGNOSTICS INC
NYSE
Diagnostics & Research
$16.44B$140.090.39%$3.00B9.13x1.10
QGEN
QIAGEN NV
NYSE
Diagnostics & Research
$10.36B$45.55-0.74%$876.07M19.38x0.91
RNLX
RENALYTIX PLC
NASDAQ
Diagnostics & Research
$126.54M$3.50-0.57%-$48.40M-2.87x0.19
SERA
SERA PROGNOSTICS INC
NASDAQ
Diagnostics & Research
$47.02M$1.52-3.80%-$39.79M-0.38x0.06
MXCT
MAXCYTE INC
NASDAQ
Diagnostics & Research
$438.65M$4.32-6.29%-$14.15M-25.41x0.11
CSTL
CASTLE BIOSCIENCES INC
NASDAQ
Diagnostics & Research
$528.11M$20.11-6.38%-$54.89M-9.86x0.12
MOTS
MOTUS GI HOLDINGS INC
NASDAQ
Diagnostics & Research
$14.21M$0.26-4.80%-$17.49M-0.50x1.84
A
AGILENT TECHNOLOGIES INC
NYSE
Diagnostics & Research
$37.34B$124.41-1.25%$1.78B31.26x1.00
PHG
KONINKLIJKE PHILIPS NV
NYSE
Diagnostics & Research
$21.96B$25.240.48%$5.37B6.05x1.14
IDXX
IDEXX LABORATORIES INC
NASDAQ
Diagnostics & Research
$30.42B$362.16-1.68%$1.04B41.87x3.05
AKU
AKUMIN INC
NASDAQ
Diagnostics & Research
$79.67M$0.891.14%$47.41M-1.02x21.23
ICLR
ICON PLC
NASDAQ
Diagnostics & Research
$17.64B$216.27-0.60%$869.61M81.61x1.13
DXCM
DEXCOM INC
NASDAQ
Diagnostics & Research
$28.27B$288.13-11.05%$390.30M132.17x1.31
BWAY
BRAINSWAY LTD
NASDAQ
Diagnostics & Research
$100.21M$6.09-4.55%-$4.30M-14.50x0.31
BMRA
BIOMERICA INC
NASDAQ
Diagnostics & Research
$38.17M$2.97-1.00%-$4.83M-7.07x0.80
CRL
CHARLES RIVER LABORATORIES INTERNATIONAL INC
NYSE
Diagnostics & Research
$11.35B$223.35-3.41%$850.56M26.65x1.69
BNGO
BIONANO GENOMICS INC
NASDAQ
Diagnostics & Research
$434.55M$1.50-4.46%-$91.56M-4.55x0.12
SENS
SENSEONICS HOLDINGS INC
NYSEMKT
Diagnostics & Research
$509.59M$1.10-5.17%$52.10M13.75x-3.10
AWH
ASPIRA WOMEN's HEALTH INC
NASDAQ
Diagnostics & Research
$50.83M$0.45-7.55%-$34.67M-1.46x0.42
CDNA
CAREDX INC
NASDAQ
Diagnostics & Research
$1.24B$23.28-2.68%-$38.23M-24.51x0.20
PRPO
PRECIPIO INC
NASDAQ
Diagnostics & Research
$24.53M$1.080.93%-$10.16M-2.12x0.26
MTD
METTLER TOLEDO INTERNATIONAL INC
NYSE
Diagnostics & Research
$27.93B$1,231.46-1.28%$1.13B35.72x38.69
DHR
DANAHER CORP
NYSE
Diagnostics & Research
$183.22B$252.00-0.44%$10.17B28.67x0.80
VIVO
MERIDIAN BIOSCIENCE INC
NASDAQ
Diagnostics & Research
$1.13B$25.97-0.04%$97.21M18.16x0.26
NRC
NATIONAL RESEARCH CORP
NASDAQ
Diagnostics & Research
$831.67M$33.010.98%$55.70M22.77x0.88
NEOG
NEOGEN CORP
NASDAQ
Diagnostics & Research
$2.85B$26.450.08%$85.21M58.13x0.12
OLK
OLINK HOLDING AB (PUBL)
NASDAQ
Diagnostics & Research
$1.27B$10.71-6.54%-$25.40M-35.70x0.14
PSNL
PERSONALIS INC
NASDAQ
Diagnostics & Research
$184.51M$4.06-6.88%-$74.50M-2.22x0.33
NTRA
NATERA INC
NASDAQ
Diagnostics & Research
$3.60B$37.34-4.38%-$514.07M-6.34x1.11
HTGM
HTG MOLECULAR DIAGNOSTICS INC
NASDAQ
Diagnostics & Research
$5.07M$0.595.36%-$16.62M-0.24x1.53
OPGN
OPGEN INC
NASDAQ
Diagnostics & Research
$16.85M$0.36-6.46%-$19.13M-0.43x0.88
SHC
SOTERA HEALTH CO
NASDAQ
Diagnostics & Research
$5.76B$20.350.25%$419.49M42.40x3.42
MYGN
MYRIAD GENETICS INC
NASDAQ
Diagnostics & Research
$1.72B$21.35-1.61%$40.40M-194.09x0.32
PACB
PACIFIC BIOSCIENCES OF CALIFORNIA INC
NASDAQ
Diagnostics & Research
$1.21B$5.39-6.10%-$241.12M-6.49x1.64
GTH
GENETRON HOLDINGS LTD
NASDAQ
Diagnostics & Research
$124.07M$1.37-4.86%-$76.72M-1.62x0.25
ANIX
ANIXA BIOSCIENCES INC
NASDAQ
Diagnostics & Research
$99.05M$3.29-0.15%-$14.52M-6.84x0.06
CHEK
CHECK-CAP LTD
NASDAQ
Diagnostics & Research
$29.50M$0.31-6.42%-$13.73M-0.67x0.10
BNR
BURNING ROCK BIOTECH LTD
NASDAQ
Diagnostics & Research
$279.59M$2.66-11.33%-$116.64M-2.23x1.50
TMO
THERMO FISHER SCIENTIFIC INC
NYSE
Diagnostics & Research
$214.84B$548.82-1.15%$11.97B28.36x1.26
WAT
WATERS CORP
NYSE
Diagnostics & Research
$19.12B$317.45-1.16%$997.14M27.58x7.11
ILMN
ILLUMINA INC
NASDAQ
Diagnostics & Research
$37.74B$240.26-1.96%$1.20B52.34x0.40
MDXH
MDXHEALTH SA
NASDAQ
Diagnostics & Research
$120.10M$7.70-5.72%-$23.79M-3.21x0.60
NOTV
INOTIV INC
NASDAQ
Diagnostics & Research
$342.16M$13.412.05%-$54.59M-4.09x0.85
XGN
EXAGEN INC
NASDAQ
Diagnostics & Research
$75.10M$4.62-0.43%-$26.90M-2.55x0.60
BIOC
BIOCEPT INC
NASDAQ
Diagnostics & Research
$23.78M$1.41-5.07%-$5.05M-2.60x0.67
LH
LABORATORY CORP OF AMERICA HOLDINGS
NYSE
Diagnostics & Research
$23.10B$249.15-0.14%$3.87B11.34x0.93
IQV
IQVIA HOLDINGS INC
NYSE
Diagnostics & Research
$38.23B$201.99-0.69%$2.83B35.75x3.22
AXDX
ACCELERATE DIAGNOSTICS INC
NASDAQ
Diagnostics & Research
$46.23M$0.580.17%-$52.76M-0.54x-2.24
ISPC
ISPECIMEN INC
NASDAQ
Diagnostics & Research
$22.31M$2.53-5.95%-$6.06M-1.98x0.20
NEO
NEOGENOMICS INC
NASDAQ
Diagnostics & Research
$969.37M$7.77-10.79%$28.71M-27.75x0.70
ONVO
ORGANOVO HOLDINGS INC
NASDAQ
Diagnostics & Research
$21.09M$2.42-3.47%-$12.01M-1.74x0.12
PKI
PERKINELMER INC
NYSE
Diagnostics & Research
$18.18B$144.11-1.62%$1.53B23.36x1.07
STIM
NEURONETICS INC
NASDAQ
Diagnostics & Research
$63.18M$2.36-4.45%-$29.04M-1.83x0.70
NVTA
INVITAE CORP
NYSE
Diagnostics & Research
$788.75M$3.44-6.78%-$369.86M-1.72x0.68
GH
GUARDANT HEALTH INC
NASDAQ
Diagnostics & Research
$3.80B$37.27-1.87%-$364.36M-9.05x3.00
CO
GLOBAL CORD BLOOD CORP
NYSE
Diagnostics & Research
$307.87M$2.531.20%N/A3.70x0.76
ME
23ANDME HOLDING CO
NASDAQ
Diagnostics & Research
$1.25B$2.80-5.08%-$196.67M-1.46x0.28
CELC
CELCUITY INC
NASDAQ
Diagnostics & Research
$91.11M$6.10-8.96%-$32.79M-2.46x0.30
LNTH
LANTHEUS HOLDINGS INC
NASDAQ
Diagnostics & Research
$4.38B$63.76-4.02%$21.02M-113.86x0.81
EXAS
EXACT SCIENCES CORP
NASDAQ
Diagnostics & Research
$8.43B$47.89-7.90%-$521.28M-11.06x0.99
NDRA
ENDRA LIFE SCIENCES INC
NASDAQ
Diagnostics & Research
$13.58M$0.22-4.44%-$11.59M-0.74x0.21
SLNO
SOLENO THERAPEUTICS INC
NASDAQ
Diagnostics & Research
$22.22M$0.19-7.50%-$25.43M-0.53x0.61
BVS
BIOVENTUS INC
NASDAQ
Diagnostics & Research
$653.43M$8.47-5.04%$18.75M-26.47x1.50
SRDX
SURMODICS INC
NASDAQ
Diagnostics & Research
$516.93M$36.950.00%-$1.67M-49.27x0.38
ENZ
ENZO BIOCHEM INC
NYSE
Diagnostics & Research
$112.52M$2.31-4.15%$2.85MN/A0.67
SQL
SEQLL INC
NASDAQ
Diagnostics & Research
$8.20M$0.690.44%-$3.00M-2.16x0.53
CEMI
CHEMBIO DIAGNOSTICS INC
NASDAQ
Diagnostics & Research
$18.77M$0.62-1.43%-$32.41M-0.42x1.37
HSKA
HESKA CORP
NASDAQ
Diagnostics & Research
$1.03B$95.17-3.24%-$1.65M-74.94x0.40
RDNT
RADNET INC
NASDAQ
Diagnostics & Research
$1.08B$19.28-1.53%$251.62M58.42x5.76
VNRX
VOLITIONRX LTD
NYSEMKT
Diagnostics & Research
$124.39M$2.31-4.15%-$27.02M-4.44x1.88
MYNZ
MAINZ BIOMED NV
NASDAQ
Diagnostics & Research
$139.68M$11.63-3.41%-$11.42M-7.18x0.58
GENE
GENETIC TECHNOLOGIES LTD
NASDAQ
Diagnostics & Research
$23.45M$1.270.79%N/AN/A0.16
CNTG
CENTOGENE NV
NASDAQ
Diagnostics & Research
$60.93M$2.70-7.53%-$26.69M-1.19x2.32
PMD
PSYCHEMEDICS CORP
NASDAQ
Diagnostics & Research
$35.20M$6.30-1.33%$2.77M-48.42x0.68
BDSX
BIODESIX INC
NASDAQ
Diagnostics & Research
$52.52M$1.32-8.97%-$43.17M-0.73x6.92
TTOO
T2 BIOSYSTEMS INC
NASDAQ
Diagnostics & Research
$35.03M$0.20-2.86%-$45.55M-0.62x-2.91
OPK
OPKO HEALTH INC
NASDAQ
Diagnostics & Research
$2.07B$3.03-2.26%-$20.30M-15.95x0.43
OCDX
ORTHO CLINICAL DIAGNOSTICS HOLDINGS PLC
NASDAQ
Diagnostics & Research
$4.22B$17.73-0.28%$488.00M-1,773.00x6.48
TRIB
TRINITY BIOTECH PLC
NASDAQ
Diagnostics & Research
$26.96M$1.294.03%$10.54MN/A-373.71
QTNT
QUOTIENT LTD
NASDAQ
Diagnostics & Research
$32.22M$0.31-8.72%-$99.57M-0.22x-2.66
LMDX
LUMIRADX LTD
NASDAQ
Diagnostics & Research
$903.48M$3.57-5.56%N/AN/A1.17
LAB
STANDARD BIOTOOLS INC
NASDAQ
Diagnostics & Research
$150.64M$1.95-25.00%-$112.00M-1.28x11.30
PRE
PRENETICS GLOBAL LTD
NASDAQ
Diagnostics & Research
$223.10M$5.08-8.63%$3.89M84.67x-1.05

Diagnostics & Research Stocks FAQ

What are the best diagnostics & research stocks to buy right now in May 2022?

According to Zen Score, the 3 best diagnostics & research stocks to buy right now are:

1. QUIDEL (NASDAQ:QDEL)


QUIDEL (NASDAQ:QDEL) is the top diagnostics & research stock with a Zen Score of 57, which is 24 points higher than the diagnostics & research industry average of 33. It passed 18 out of 33 due diligence checks and has strong fundamentals. QUIDEL has seen its stock lose -12.94% over the past year, overperforming other diagnostics & research stocks by 9 percentage points.

QUIDEL has an average 1 year price target of $145.00, an upside of 44.42% from QUIDEL's current stock price of $100.40.

QUIDEL stock has a consensus Hold recommendation according to Wall Street analysts. Of the 3 analysts covering QUIDEL, 33.33% have issued a Strong Buy rating, 33.33% have issued a Buy, 0% have issued a hold, while 0% have issued a Sell rating, and 33.33% have issued a Strong Sell.

2. -DIAGNOSTICS (NASDAQ:CODX)


-DIAGNOSTICS (NASDAQ:CODX) is the second best diagnostics & research stock with a Zen Score of 53, which is 20 points higher than the diagnostics & research industry average of 33. It passed 17 out of 33 due diligence checks and has strong fundamentals. -DIAGNOSTICS has seen its stock lose -43.46% over the past year, underperforming other diagnostics & research stocks by -22 percentage points.

-DIAGNOSTICS has an average 1 year price target of $12.00, an upside of 164.32% from -DIAGNOSTICS's current stock price of $4.54.

-DIAGNOSTICS stock has a consensus Buy recommendation according to Wall Street analysts. Of the 1 analyst covering -DIAGNOSTICS, 0% have issued a Strong Buy rating, 100% have issued a Buy, 0% have issued a hold, while 0% have issued a Sell rating, and 0% have issued a Strong Sell.

3. SYNEOS HEALTH (NASDAQ:SYNH)


SYNEOS HEALTH (NASDAQ:SYNH) is the third best diagnostics & research stock with a Zen Score of 52, which is 19 points higher than the diagnostics & research industry average of 33. It passed 17 out of 33 due diligence checks and has strong fundamentals. SYNEOS HEALTH has seen its stock lose -20.46% over the past year, overperforming other diagnostics & research stocks by 1 percentage points.

SYNEOS HEALTH has an average 1 year price target of $98.86, an upside of 40.1% from SYNEOS HEALTH's current stock price of $70.56.

SYNEOS HEALTH stock has a consensus Strong Buy recommendation according to Wall Street analysts. Of the 8 analysts covering SYNEOS HEALTH, 62.5% have issued a Strong Buy rating, 12.5% have issued a Buy, 25% have issued a hold, while 0% have issued a Sell rating, and 0% have issued a Strong Sell.

What are the diagnostics & research stocks with highest dividends?

Out of 9 diagnostics & research stocks that have issued dividends in the past year, the 3 diagnostics & research stocks with the highest dividend yields are:

1. KONINKLIJKE PHILIPS NV (NYSE:PHG)


KONINKLIJKE PHILIPS NV (NYSE:PHG) has an annual dividend yield of 3.82%, which is 3 percentage points higher than the diagnostics & research industry average of 1.1%. KONINKLIJKE PHILIPS NV's dividend payout is not stable, having dropped more than 10% three times in the last 10 years. KONINKLIJKE PHILIPS NV's dividend has not shown consistent growth over the last 10 years.

KONINKLIJKE PHILIPS NV's dividend payout ratio of 24.8% indicates that its dividend yield is sustainable for the long-term.

2. NATIONAL RESEARCH (NASDAQ:NRC)


NATIONAL RESEARCH (NASDAQ:NRC) has an annual dividend yield of 1.82%, which is 1 percentage points higher than the diagnostics & research industry average of 1.1%. NATIONAL RESEARCH's dividend payout is not stable, having dropped more than 10% three times in the last 10 years. NATIONAL RESEARCH's dividend has shown consistent growth over the last 10 years.

NATIONAL RESEARCH's dividend payout ratio of 41.4% indicates that its dividend yield is sustainable for the long-term.

3. QUEST DIAGNOSTICS (NYSE:DGX)


QUEST DIAGNOSTICS (NYSE:DGX) has an annual dividend yield of 1.8%, which is 1 percentage points higher than the diagnostics & research industry average of 1.1%. QUEST DIAGNOSTICS's dividend payout is stable, having never dropped by more than 10% in the last 10 years. QUEST DIAGNOSTICS's dividend has shown consistent growth over the last 10 years.

QUEST DIAGNOSTICS's dividend payout ratio of 16.4% indicates that its dividend yield is sustainable for the long-term.

Why are diagnostics & research stocks down?

Diagnostics & research stocks were down -2.05% in the last day, and down -2.25% over the last week. DEXCOM was the among the top losers in the diagnostics & research industry, dropping -11.05% yesterday.

DexCom shares are trading lower following a Bloomberg report suggesting the company is in talks to acquire Insulet.

What are the most undervalued diagnostics & research stocks?

Based on WallStreetZen's Valuation Score, the 3 most undervalued diagnostics & research stocks right now are:

1. -DIAGNOSTICS (NASDAQ:CODX)


-DIAGNOSTICS (NASDAQ:CODX) is the most undervalued diagnostics & research stock based on WallStreetZen's Valuation Score. -DIAGNOSTICS has a valuation score of 71, which is 38 points higher than the diagnostics & research industry average of 33. It passed 5 out of 7 valuation due diligence checks.

-DIAGNOSTICS's stock has dropped -43.46% in the past year. It has underperformed other stocks in the diagnostics & research industry by -22 percentage points.

2. QUIDEL (NASDAQ:QDEL)


QUIDEL (NASDAQ:QDEL) is the second most undervalued diagnostics & research stock based on WallStreetZen's Valuation Score. QUIDEL has a valuation score of 71, which is 38 points higher than the diagnostics & research industry average of 33. It passed 5 out of 7 valuation due diligence checks.

QUIDEL's stock has dropped -12.94% in the past year. It has overperformed other stocks in the diagnostics & research industry by 9 percentage points.

3. MERIDIAN BIOSCIENCE (NASDAQ:VIVO)


MERIDIAN BIOSCIENCE (NASDAQ:VIVO) is the third most undervalued diagnostics & research stock based on WallStreetZen's Valuation Score. MERIDIAN BIOSCIENCE has a valuation score of 71, which is 38 points higher than the diagnostics & research industry average of 33. It passed 5 out of 7 valuation due diligence checks.

MERIDIAN BIOSCIENCE's stock has gained 30.11% in the past year. It has overperformed other stocks in the diagnostics & research industry by 52 percentage points.

Are diagnostics & research stocks a good buy now?

47.62% of diagnostics & research stocks rated by analysts are a strong buy right now. On average, analysts expect diagnostics & research stocks to rise by 48.05% over the next year.

What is the average p/e ratio of the diagnostics & research industry?

The average P/E ratio of the diagnostics & research industry is 21.48x.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.